mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.34 |
4e-12 |
mRNA |
GDC-0879 |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
1e-10 |
mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
2e-09 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
9e-07 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-06 |
mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
6e-06 |
mRNA |
Irinotecan |
gCSI |
pan-cancer |
AAC |
-0.26 |
6e-06 |
mRNA |
cimetidine |
CTRPv2 |
pan-cancer |
AAC |
0.31 |
1e-05 |
mRNA |
dabrafenib |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
1e-05 |
mRNA |
Gemcitabine |
gCSI |
pan-cancer |
AAC |
-0.26 |
1e-05 |